This federal contract award, SPE2D020D0009|SPE2D325F6842, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $2,237.97 firm fixed-price delivery order is for the supply of Ketorolac Tromethamine Injection (Toradol 30mg/mL), a critical care pharmaceutical used for pain management.
The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued at $2,237,072.60, held by Fresenius Kabi with the National Acquisition Center of the Department of Veterans Affairs. This IDC covers the supply of Bortezomib vials, a cancer treatment drug, to multiple federal healthcare systems including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract has an ordering period from March 11, 2023, through March 10, 2024, with four potential one-year option periods.
Generated 6/1/25, 2:56 AM